BLU-808

· Blueprint Medicines Corporation

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for BLU-808, covering 2025-04-28 to 2026-02-17. Get the full timeline:

Most recent: Clinical Trial Update: Study of BLU-808 in Chronic Inducible Urticaria (CIndU) and Chronic Spontaneous Urticaria (CSU) [Phase 2]